Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

#Immunotherapy

Home » #Immunotherapy
ASH 2024 | Dr. Wenming Chen: Precision and Immune-Targeted Therapies to Overcome R/R MM Challenges

ASH 2024 | Dr. Wenming Chen: Precision and Immune-Targeted Therapies to Overcome R/R MM Challenges

Posted by By Mourabit Halima 2024.12.31
Editor's Note: The 66th Annual Meeting of the American Society of Hematology (ASH) took place in San Diego from December 7 to 10, 2024. This prestigious event brought together global…
Read More
Dr. Tao Chen: Insights on the “Expert Consensus on Thymosin Alpha-1 in Infectious Diseases and Critical Illness” | CCIFLDI 2024

Dr. Tao Chen: Insights on the “Expert Consensus on Thymosin Alpha-1 in Infectious Diseases and Critical Illness” | CCIFLDI 2024

Posted by By Mourabit Halima 2024.11.08
Editor’s Note: With growing attention to immunotherapy, thymosin alpha-1 (Tα1), a bioactive peptide composed of 28 amino acids with immunomodulatory effects, is increasingly applied in infectious diseases and critical care.…
Read More
Minimally Invasive Surgery and Immunotherapy Dr. Yongde Liao Discusses New Pathways in Esophageal Cancer Treatment | CACA Integrated Esophageal Cancer

Minimally Invasive Surgery and Immunotherapy Dr. Yongde Liao Discusses New Pathways in Esophageal Cancer Treatment | CACA Integrated Esophageal Cancer

Posted by By Lisa Cui 2024.10.26
Editor's Note: From September 26 to 28, 2024, the 2024 CACA Integrated Esophageal Cancer Academic Conference, hosted by the Chinese Anti-Cancer Association and the CACA Esophageal Cancer Committee, was successfully…
Read More
ILCA 2024 Reveals: Sorafenib-Toripalimab and Anlotinib-Sintilimab Combos Yield Unprecedented Results in Liver Cancer

ILCA 2024 Reveals: Sorafenib-Toripalimab and Anlotinib-Sintilimab Combos Yield Unprecedented Results in Liver Cancer

Posted by By Mourabit Halima 2024.10.25
Editor’s Note: From October 17-19, 2024, global experts and scholars in liver cancer research gathered in Toronto, Canada, to witness the 18th International Liver Cancer Association (ILCA) Annual Conference. At…
Read More
Advancing Liver Cancer Treatment: Insights from Professor Tim Meyer

Advancing Liver Cancer Treatment: Insights from Professor Tim Meyer

Posted by By Peng Longmei 2024.10.23
In a recent discussion, Professor Tim Meyer highlighted the importance of multidisciplinary care in liver cancer treatment. As systemic therapies evolve, including combinations of tyrosine kinase inhibitors and immunotherapy, there’s…
Read More
Dr. Yinying Lu: Close Relationship Between Gut Microbiota and Hepatobiliary Tumors

Dr. Yinying Lu: Close Relationship Between Gut Microbiota and Hepatobiliary Tumors

Posted by By Peng Longmei 2024.09.09
Editor’s note: The gut microbiota is one of the most complex microbial communities in the human body and plays a crucial role in both health and disease development. Recently, at…
Read More
Dr. Thomas Powles: ADC combined with immunotherapy promises to reshape the treatment landscape for urothelial cancer

Dr. Thomas Powles: ADC combined with immunotherapy promises to reshape the treatment landscape for urothelial cancer

Posted by By Mourabit Halima 2024.05.10
Editor's Note: The landscape of advanced urothelial cancer (UC) treatment is rapidly evolving. Historically dominated by platinum-based chemotherapies, recent years have seen a paradigm shift towards more targeted therapies and…
Read More
EAU24 Interview | Dr. Jens Bedke：Innovations in Advanced Urothelial Carcinoma Treatment

EAU24 Interview | Dr. Jens Bedke：Innovations in Advanced Urothelial Carcinoma Treatment

Posted by By Mourabit Halima 2024.04.29
Editor's note: Platinum-based chemotherapy remains the cornerstone of treatment for advanced urothelial cancer (UC), but it still does not meet the long-term survival needs of patients; the 39th European Association…
Read More
Neutrophil Plasticity in Cancer: A Gateway to Targeted Immunotherapy

Neutrophil Plasticity in Cancer: A Gateway to Targeted Immunotherapy

Posted by By Mourabit Halima 2024.03.15
Editor's note: Neutrophils, once viewed as uniform soldiers of the immune system, are now recognized for their remarkable plasticity within the tumor microenvironment. In a pioneering study led by Melissa…
Read More
Dr. Guohong Han: Combining Targeted Therapy to Reduce Postoperative Liver Cancer Recurrence and Prolong Survival in Cirrhotic Patients with Anticoagulation

Dr. Guohong Han: Combining Targeted Therapy to Reduce Postoperative Liver Cancer Recurrence and Prolong Survival in Cirrhotic Patients with Anticoagulation

Posted by By Mourabit Halima 2024.02.16
The 58th Annual Meeting of the European Association for the Study of the Liver (EASL 2023) and the 2023 EASL Congress concluded successfully on June 24th in Vienna, Austria, three…
Read More

Posts pagination

1 2 Next page
Recent Posts
  • ESMO China Voice | Professor Jiesong Wang: The iPET-NCCN-IPI Model May Optimize Risk Stratification in Diffuse Large B-Cell Lymphoma
  • ESMO China Voice | Dr. Sicong Zhang: Refractory DLBCL Patients Share Similar Immune Signatures
  • ESMO China Voice | Dr. Cong Sun: Grade 3B Follicular Lymphoma Is an Independent Risk Factor Affecting Both PFS and OS
  • ESMO China Voice | Prof. Liang Wang: CD19/CD22 Bispecific CAR-T Therapy Demonstrates Remarkable Efficacy and Safety in R/R LBCL
  • 13th FACO Annual Academic Conference Grandly Held in Shanghai! Leading Experts from China, Japan, and South Korea Gather to Foster Clinical Oncology
Recent Comments
    Archives
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2025 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Media Medic Publishing Company Limited(HK)
    赛美出版有限公司（香港）
    Scroll to Top